| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2009 | US20090233899 Crystalline Modification of Cefuroximaxetil |
| 09/17/2009 | US20090233898 Pharmaceutical Compositions Comprising Simvastatin and Ezetimibe |
| 09/17/2009 | US20090233897 Potassium Channel Inhibitors |
| 09/17/2009 | US20090233896 Inhibitors of checkpoint kinases |
| 09/17/2009 | US20090233895 Method of treatment of bacterial infections |
| 09/17/2009 | US20090233894 Compounds and Methods For The Treatment of Cancer |
| 09/17/2009 | US20090233893 Methods of Dissolving Beta-Sheet Proteins and Uses Thereof |
| 09/17/2009 | US20090233892 Topical Compositions Comprising Hydrocortisone Butyrate |
| 09/17/2009 | US20090233891 Pharmaceutical lotion comprising fluticasone propionate |
| 09/17/2009 | US20090233890 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 09/17/2009 | US20090233889 Stabilized 1,25-dihydroxyvitamin d2 and method of making same |
| 09/17/2009 | US20090233888 Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| 09/17/2009 | US20090233887 Hydroswellable, Segmented, Aliphatic Polyurethanes and Polyurethane Ureas |
| 09/17/2009 | US20090233886 Derivatives of 4- or 5-aminosalicylic acid |
| 09/17/2009 | US20090233885 Compositions and Methods for Fat Reduction |
| 09/17/2009 | US20090233884 Use of cyclipostin derivatives for the treatment of mycobacterial infectious diseases |
| 09/17/2009 | US20090233883 Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| 09/17/2009 | US20090233882 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 09/17/2009 | US20090233881 Compounds having anti-cancer properties |
| 09/17/2009 | US20090233880 Equol production accelerating composition |
| 09/17/2009 | US20090233879 Novel nucleoside derivatives |
| 09/17/2009 | US20090233878 Novel adenosine a3 receptor agonists |
| 09/17/2009 | US20090233877 Avermectin compounds and treatment of dermatological disorders therewith |
| 09/17/2009 | US20090233876 Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives |
| 09/17/2009 | US20090233875 Glycolipids and analogues thereof as antigens for nk t cells |
| 09/17/2009 | US20090233874 Including canagliflozin 1-(beta-D-glucopyransoyl)-4-methyl-3-(5-(4-fluorophenyl)-2 -thienylmethyl)benzene; sodium-dependent glucose transporter (SGLT); obesity, diabetes |
| 09/17/2009 | US20090233873 Nitric oxide donors |
| 09/17/2009 | US20090233872 Therapeutic Agent for Neurodegenerative Disease |
| 09/17/2009 | US20090233868 Small antiviral peptides against hepatitis C virus |
| 09/17/2009 | US20090233865 Nutritional Compositions |
| 09/17/2009 | US20090233862 Compositions and methods for treatment of optic nerve diseases |
| 09/17/2009 | US20090233857 Dna vaccine compositions and methods of use |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233843 Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 09/17/2009 | US20090233841 Analgesic conjugates |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090232961 Mineral-absorption promoter, food and feed |
| 09/17/2009 | US20090232940 Process for producing 1,4-dihydoxy-2-naphthoic acid |
| 09/17/2009 | US20090232919 Composition Comprising Liquiritigenin for Preventing and Treating Liver Disease |
| 09/17/2009 | US20090232917 Composition for relieving subjective symptoms of fatigue |
| 09/17/2009 | US20090232916 Food products for diabetics |
| 09/17/2009 | US20090232913 Composition for the Control of Cholesterol Levels |
| 09/17/2009 | US20090232912 Method For Preparing Extract For The Prevention and Treatment Of Hyperlipidemia and Obesity From the Extract of Aster Spathulifolius Aerial Part and Composition Containing The Same |
| 09/17/2009 | US20090232910 Biomarkers and therapeutics targets for cognitive decline |
| 09/17/2009 | US20090232909 Method for determining physiological effects of hemoglobin |
| 09/17/2009 | US20090232908 Stable aqueous solution containing sodium pyruvate, and the preparation and use thereof |
| 09/17/2009 | US20090232907 Compositions and methods for treatment of esophageal cancer |
| 09/17/2009 | US20090232906 Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
| 09/17/2009 | US20090232900 Nano-micellar preparation of anthracylcline antitumor antibiotics encapsulated by the phosphatide derivatized with polyethylene glycol |
| 09/17/2009 | US20090232899 Mucoadhesive nanocomposite delivery system |
| 09/17/2009 | US20090232898 Pharmaceutical Compositions Useful in the Treatment of Migraine |
| 09/17/2009 | US20090232897 Pharmaceutical compositions comprising conjugated estrogens |
| 09/17/2009 | US20090232893 miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 09/17/2009 | US20090232892 Cellooligosaccharide-Containing Composition |
| 09/17/2009 | US20090232889 Crystalline salts of quinoline compounds and methods for preparing them |
| 09/17/2009 | US20090232888 Sustained delivery of antibiotics |
| 09/17/2009 | US20090232886 Oral dosage combination pharmaceutical packaging |
| 09/17/2009 | US20090232885 Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids |
| 09/17/2009 | US20090232880 Analogue Compounds Of Archaebacterial Membrane Lipids And Liposomal Compounds Integrating Such Compounds |
| 09/17/2009 | US20090232879 Thyromimetics for the Treatment of Fatty Liver Diseases |
| 09/17/2009 | US20090232877 Method and composition for in situ formation and/or expansion of a polymer-based hemostatic agent to control bleeding |
| 09/17/2009 | US20090232874 Fibrous membrane for biomedical application based on poly(ester-amide)s |
| 09/17/2009 | US20090232868 Nitric Oxide Releasing Polymer Composition |
| 09/17/2009 | US20090232866 Oligopeptides as coating material for medical products |
| 09/17/2009 | US20090232865 End-Capped Poly(Ester Amide) Copolymers |
| 09/17/2009 | US20090232853 Treatment of laminitis |
| 09/17/2009 | US20090232847 Immunogenic compositions |
| 09/17/2009 | US20090232844 Immunopotentiating compounds |
| 09/17/2009 | US20090232843 Identifying and predicting influenza variants and uses thereof |
| 09/17/2009 | US20090232841 Optimzed vaccines to provide protection against ebola and other viruses |
| 09/17/2009 | US20090232833 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/17/2009 | US20090232831 Methods and compositions for the treatment or prevention of human immunodeficiency virus infection |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232829 Methods and compositions for treating inflammatory conditions |
| 09/17/2009 | US20090232828 Methods of Using IGFIR and ABL Kinase Modulators |
| 09/17/2009 | US20090232827 Compositions and methods of use of compounds to increase cancer patient survival time |
| 09/17/2009 | US20090232825 Methods and Compositions For Modulating Immunity |
| 09/17/2009 | US20090232821 Use Of A Growth-Stimulating Protein |
| 09/17/2009 | US20090232814 Cancer biomarker genes and gene products and methods for using the same |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232800 E1-minus adenoviruses and use thereof |
| 09/17/2009 | US20090232796 Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand |
| 09/17/2009 | US20090232794 Modulators of neuronal regeneration |
| 09/17/2009 | US20090232780 Compounds that enhance atoh1 expression |
| 09/17/2009 | US20090232776 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 09/17/2009 | US20090232773 Method for Distinguishing Mesenchymal Stem Cell Using Molecular Marker and Use Thereof |
| 09/17/2009 | US20090232769 Pharmaceutical Composition For Treatment Of Blood Clotting Disorder |
| 09/17/2009 | US20090232768 Novel compounds and methods for therapy |
| 09/17/2009 | US20090232764 Triblock polymers and polymer coatings |
| 09/17/2009 | US20090232763 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 09/17/2009 | US20090232762 Compositions for delivery of therapeutic agents |
| 09/17/2009 | US20090232756 Cosmetic composition comprising an ascorbic acid or salicylic acid compound |
| 09/17/2009 | US20090232755 Combination therapies for treating photodamaged skin |
| 09/17/2009 | US20090232754 Enhanced photostability of suncare compositions containing avobenzone |
| 09/17/2009 | US20090232753 Gel compositions |
| 09/17/2009 | US20090232750 Compositions for indoor tanning |
| 09/17/2009 | US20090232748 Virucidal activities of cetylpyridinium chloride |
| 09/17/2009 | US20090232744 Macrolide compositions having improved taste and stability |
| 09/17/2009 | US20090232743 Foamable Microemulsion Compositions for Topical Administration |
| 09/17/2009 | US20090232738 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity |